Literature DB >> 17426784

Evaluation of urine N1,N12-Diacetylspermine as potential tumor marker for urinary bladder cancer.

David Stejskal1, Viera Humenanska, Zuzana Hanulova, Richard Fiala, Radovan Vrtal, Pavlina Solichova, Michal Karpisek.   

Abstract

BACKGROUND: N1,N12-diacetylspermine, a diacetylpolyamine which was recently identified in urine, appeared to be a useful tumor marker for a number of cancers. No valid data on urine diacetylspermine concentration in patients with urinary bladder cancer exist. AIM: Evaluation of urine N1,N12-diacetylspermine concentrations in individuals with urinary bladder cancer.
METHODS: Urine samples were used from 36 patients with urothelial tumors of the urinary bladder and from 30 patients with benign urological diseases. Urine was collected before cystoscopy. Enzyme-linked immunoabsorbent assays (ELISA) were performed for diacetylspermine from urine.
RESULTS: Urine diacetylspermine did not differentiate in individuals with urinary bladder cancer from controls (medians 171.5 vs 143.8, p = 0.64). Its efficacy for urinary bladder cancer detection was not shown.
CONCLUSIONS: Urine N1,N12-diacetylspermine is probably not a useful marker for urinary bladder cancer.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17426784     DOI: 10.5507/bp.2006.033

Source DB:  PubMed          Journal:  Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub        ISSN: 1213-8118            Impact factor:   1.245


  4 in total

1.  Urinary Metabolomics to Identify a Unique Biomarker Panel for Detecting Colorectal Cancer: A Multicenter Study.

Authors:  Lu Deng; Kathleen Ismond; Zhengjun Liu; Jeremy Constable; Haili Wang; Olusegun I Alatise; Martin R Weiser; T P Kingham; David Chang
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-05-31       Impact factor: 4.254

2.  Metabolomics: beyond biomarkers and towards mechanisms.

Authors:  Caroline H Johnson; Julijana Ivanisevic; Gary Siuzdak
Journal:  Nat Rev Mol Cell Biol       Date:  2016-03-16       Impact factor: 94.444

3.  Cerebrospinal fluid metabolomic profiles can discriminate patients with leptomeningeal carcinomatosis from patients at high risk for leptomeningeal metastasis.

Authors:  Byong Chul Yoo; Jun Hwa Lee; Kyung-Hee Kim; Weiwei Lin; Jong Heon Kim; Jong Bae Park; Hyun Jin Park; Sang Hoon Shin; Heon Yoo; Ji Woong Kwon; Ho-Shin Gwak
Journal:  Oncotarget       Date:  2017-09-18

Review 4.  The Potential Role of Spermine and Its Acetylated Derivative in Human Malignancies.

Authors:  Ryan Tsz-Hei Tse; Christine Yim-Ping Wong; Peter Ka-Fung Chiu; Chi-Fai Ng
Journal:  Int J Mol Sci       Date:  2022-01-23       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.